Pfizer Tries To Head Off UniQure Hemophilia Patent
Pfizer has asked a London court to ax a Dutch biotech company's patent covering a specific protein used to treat a rare genetic form of hemophilia, claiming that the patent covers...To view the full article, register now.
Already a subscriber? Click here to view full article